2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q2 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,886,077 | -82.4% | 736,244 | -54.7% | 0.00% | -66.7% |
| Q2 2023 | $16,437,430 | -7.8% | 1,624,252 | -7.1% | 0.00% | -25.0% |
| Q1 2023 | $17,824,725 | +81.0% | 1,747,522 | +66.2% | 0.00% | +100.0% |
| Q4 2022 | $9,849,210 | -36.0% | 1,051,143 | -0.7% | 0.00% | -50.0% |
| Q3 2022 | $15,397,000 | +246.9% | 1,058,219 | +214.7% | 0.00% | +300.0% |
| Q2 2022 | $4,439,000 | +122.1% | 336,309 | +187.0% | 0.00% | – |
| Q1 2022 | $1,999,000 | -84.7% | 117,185 | -77.0% | 0.00% | -100.0% |
| Q4 2021 | $13,031,000 | – | 508,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |